Skip to content ↓

MIT releases endowment figures for 2012

MIT's Great Dome

The Massachusetts Institute of Technology Investment Management Company (MITIMCo) announced today that MIT's unitized pool of endowment and other funds generated an investment return of 8.0 percent during the fiscal year ending June 30, 2012. At the end of that fiscal year, MIT’s endowment funds totaled $10.3 billion, including pledges.

The goal of MIT’s endowment is to support current and future generations of MIT scholars with the resources they need. As such, endowment funds are used for Institute activities including education, research, capital projects, faculty work and student financial aid.

The Institute’s need-blind undergraduate admissions policy ensures that an MIT education is accessible to all qualified candidates regardless of financial resources. MIT provides financial aid to meet the full cost of an MIT education, based on the calculated need of the family. In 2011-12, the average need-based financial aid package was $40,053. Currently, 64 percent of MIT students receive need-based financial aid, and 33 percent of MIT students receive sufficient scholarship funding that they pay no tuition.

MITIMCo’s investment policy is focused on the primary goal of generating high real rates of return without exceptional volatility. The unitized pool is primarily invested in equities and heavily weighted toward markets such as private equity, real estate and marketable alternatives. For the past ten years, MIT’s unitized pool of endowment and other funds has earned an annualized return of 9.7 percent.

MITIMCo is a division of the Massachusetts Institute of Technology, created to manage and oversee the investment of the Institute's endowment, retirement and operating funds. As of June 30, 2012, MITIMCo had more than $15 billion of total assets under management.

Related Links

Related Topics

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story